QOL Medical Revenue and Competitors

Vero Beach, FL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • QOL Medical's estimated annual revenue is currently $27.3M per year.(i)
  • QOL Medical's estimated revenue per employee is $201,000

Employee Data

  • QOL Medical has 136 Employees.(i)
  • QOL Medical grew their employee count by 0% last year.

QOL Medical's People

NameTitleEmail/Phone
1
VP Manufacturing OperationsReveal Email/Phone
2
VP MarketingReveal Email/Phone
3
ControllerReveal Email/Phone
4
IT ManagerReveal Email/Phone
5
Marketing and Content ManagerReveal Email/Phone
6
Executive Rare Disease Territory ManagerReveal Email/Phone
7
Senior Clinical Project ManagerReveal Email/Phone
8
Operations ManagerReveal Email/Phone
9
Quality Control SupervisorReveal Email/Phone
10
Quality Assurance Specialist Drug ProductReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.5M132N/AN/AN/A
#2
$10.1M5014%N/AN/A
#3
$282.6M1406N/AN/AN/A
#4
$13.9M6944%N/AN/A
#5
$11.3M564%N/AN/A
#6
$11.5M57-7%N/AN/A
#7
$211.7M10724%N/AN/A
#8
$24.1M1205%N/AN/A
#9
$7.8M39-2%N/AN/A
#10
$12.9M64-2%N/AN/A
Add Company

What Is QOL Medical?

QOL Medical is a specialty biopharmaceutical company dedicated to improving the quality of life for patients with rare diseases, for their families, and for the physicians and caregivers who support them. We are a patient-centric company focused on the acquisition and commercialization of orphan products for the treatment of rare diseases.The company currently markets two FDA-approved prescription medications. Please see our Community Guidelines at: http://bit.ly/1KPdKqP Contact us by Phone: 1-866-469-3773 Contact us by Email: info@qolmed.com

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

N/A

Total Funding

136

Number of Employees

$27.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

QOL Medical News

2022-04-20 - Microsclerotherapy Treatment Market by Revenue, Present ...

Key players operating in the global microsclerotherapy treatment market are Surgimedix, Inc., Merz Pharma GmbH & Co. KGaA, QOL Medical LLC,...

2022-04-20 - Cough-Specific QOL Linked to Poor Outcomes in ILD Patients

Poor cough-specific quality of life (QOL) was independently associated ... Salt Lake City, Utah, told Medscape Medical News in an email.

2022-04-17 - QOL Medical, LLC Selects Optum Frontier Therapies as an ...

QOL Medical is a specialty biopharmaceutical company dedicated to improving clinical outcomes and overall quality of life for patients with rare...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M1363%N/A
#2
$15M1465%N/A
#3
$45.1M15218%N/A
#4
$39.9M1654%N/A
#5
$35M175N/AN/A